To evaluate the clinicopathological impact and prognostic significance of VEGFR1 and VEGFR2 expressions, another tissue array containing 86 cases of ESCC collected prospectively by our group was used. The gene discussed is FLT1; the disease is esophageal squamous cell carcinoma.